Researchers at PNNL studied the effects of high temperatures and ionizing radiation on tungsten heavy alloys.

PNNL researchers co-organized a workshop on fusion commercialization with partners from industry and academia

Scientists are developing ways to detect previously unseen forms of fentanyl as well as other synthetic opioids known as nitazenes.

PNNL researchers will pursue both fundamental and applied projects with this support from the Department of Energy

A cross-institutional team of scientists developed PeakQC, a new software tool for automated quality control of mass spectrometry data.

Combining cold spray deposition and friction stir processing for a more efficient route to oxide dispersion strengthened steel.

PNNL researchers studied the microstructure of lithium silicates under emulated fusion conditions.

Ljiljana Paša-Tolić, a PNNL fellow, is the recipient of the 2024 International Mass Spectrometry Foundation’s Jochen Franzen Award. 

Scientists have developed a way to detect tiny amounts of hard-to-detect explosives more than eight feet away.

Researchers studied the boundary precipitation of tungsten heavy alloys in an extended high temperature irradiation environment

A team of researchers from Pacific Northwest National Laboratory and the Environmental Molecular Sciences Laboratory developed a new and flexible software tool called “Advanced Spectra PCA Toolbox.”

The Department of Energy Office of Nuclear Energy acting assistant secretary makes his first visit to a national laboratory in his new role, touring PNNL's Radiochemical Processing Laboratory.

Vigorous exercise burns fat more in males than in females, but the benefits of exercise are broad for both sexes.

Three PNNL-affiliated researchers have been named fellows of the American Association for the Advancement of Science, the world’s largest multidisciplinary scientific society.

PNNL research exploring tungsten heavy alloys for use in advanced nuclear fusion reactors makes Scientific Reports Top 100 Collection.

Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

PNNL scientists took thousands of measurements of firefighters in training to learn more about how the body responds to vigorous exercise.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.